Transformed Indolent Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB06769Bendamustine2Unknown Status1
DB09053Ibrutinib2Unknown Status1
DB00073Rituximab2Unknown Status1